Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

FDA approval was also granted in early 2025 to Susvimo (Roche) for the treatment of DME, which continuously delivers ranibizumab via the Port Delivery Platform, a refillable (every six months) eye ...

Roche’s move into digital pathology has been lifted by FDA approval of its digital pathology toolkit as an aid to clinical diagnosis.

SNS Insider Reveals Sharp Growth in U.S. Retinal Biologics Market, Valued at USD 9.70 Billion in 2023 Capturing Over 43% Global Share Amid FDA Approvals, VEGF-A Dominance, and Accelerating R&D in ...

The latest international Roche Holding AG news and views from Reuters - one of the world's largest news agencies ...

Get Roche Holding AG (ROG.S) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ...